Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price on Feb 6, 2026
Generation Bio Co. Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Generation Bio Co. stock had an average target of $8.88, with a low estimate of $5.00 and a high estimate of $15.
Price Target: $8.88 (+66.29%)
Analyst Consensus: Buy
Price Target
Analyst Ratings
The average analyst rating for Generation Bio Co. stock from 5 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
11.21M
from 19.89M
Decreased by -43.64%
Revenue Next Year
n/a
from 11.21M
EPS This Year
-13.25
from -19.76
EPS Next Year
-5.99
from -13.25
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 12.9M | n/a | ||||
| Avg | 11.2M | n/a | ||||
| Low | 9.3M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -35.1% | - | ||||
| Avg | -43.6% | - | ||||
| Low | -53.2% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -12.63 | -0.27 | |
| Avg | -13.25 | -5.99 | |
| Low | -13.66 | -12.09 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |